Читать «Диета для ума. Научный подход к питанию для здоровья и долголетия» онлайн - страница 171

Лайза Москони

6. Pardridge W. M., Mietus L. J. Journal of Neurochemistry 1980; 34:463–466.

7. Mitchell R. W. et al. Journal of Neurochemistry 2011; 117:735–746.

8. Sastry P. S. Progress in Lipids Research 1985; 24:69–176.

9. Bachelard H. S. Brain Biochemistry (2nd edition). London: Chapman and Hall, 1981.

10. Edmond J. Journal of Molecular Neuroscience 2001; 16:181–193.

11. Williams C. M., Burdge G. Proceedings of the Nutrition Society 2006; 65:42–50.

12. Morris M. C., Tangney C. C. Neurobiology of Aging 2014; 35 Suppl 2:59–64.

13. Simopoulos A. P. American Journal of Clinical Nutrition 1991; 54:438–463.

14. Kris-Etherton P. M. et al. American Journal of Clinical Nutrition 2000; 71:S179–188.

15. Food and Nutrition Board of the Institute of Medicine of the National Academies. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (2002/2005).

16. Morris M. C. et al. Archives of Neurology 2003; 60:194–200.

17. Pottala J. V. et al. Neurology 2015; 82:435–442.

18. Fotuhi M. et al. Nature Clinical Practice Neurology 2009; 5:140–152.

19. Tan Z. S. et al. Neurology 2012; 78:658–664.

20. Fotuhi M. et al. Nature Clinical Practice Neurology 2009; 5:140–152.

21. Morris M. C., Tangney C. C. Neurobiology of Aging 2014; 35 Suppl 2: S59–S64.

22. Fernstrom M. H. Nutritional Pharmacology. New York: Liss AR Inc., 1981.

23. Morris M. C. et al. Archives of Neurology 2003; 60:194–200.

24. Djoussé L., Gaziano J. M. Current Atherosclerosis Reports 2009; 1:418–422.

25. Morris M. C. et al. Archives of Neurology 2003; 60:194–200.

26. Okereke O. I. et al. Annals of Neurology 2012; 72:124–134.

27. Barnard N. D. et al. Neurobiology of Aging 2014; 35:65–73S.

28. Morris M. C. et al. Archives of Neurology 2003; 60:194–200.

29. Mensink R. P., Katan M. B. New England Journal of Medicine 1990; 323:439–445.

30. Food and Drug Administration (11 July 2003). «FDA food labeling: trans fatty acids in nutrition labeling; consumer research to consider nutrient content and health claims and possible footnote or disclosure statements», p. 41059.

31. Orth M., Bellosta S. Cholesterol 2012; 2012:292–298.

32. Di Paolo G., Kim T. W. Nature Reviews Neuroscience 2011; 12:284–296.

33. Kivipelto M. et al. Annals of Internal Medicine 2002; 137:149–155.

34. Solomon A. et al. Dementia Geriatric Cognitive Disorders 2009; 28:75–80.

35. Kanter M. et al. Advances in Nutrition 2012; 3:711–717.

36. Djoussé L., Gaziano J. M. Current Atherosclerosis Reports 2009; 1:418–422.

37. Orth M., Bellosta S. Cholesterol 2012; 12:292–298.

38. Orth M., Bellosta S. Cholesterol 2012; 12:292–298.

39. Berg J. M. et al. Biochemistry (5th edition). New York: W H Freeman, 2002.

40. Mitchell R. W. et al. Journal of Neurochemistry 2011; 117:735–746.

ГЛАВА 5

1. Laterra J. et al. Blood-Brain Barrier. In Siegel G. J., Agranoff B. W., Albers R. W. et al., eds. Basic Neurochemistry: Molecular, Cellular and Medical Aspects (6th edition). Philadelphia: Lippincott-Raven, 1999.

2. Kandel E. R. et al. Principles of Neural Science (5th Edition). New York: McGraw-Hill, 2012.